COMMUNIQUÉS West-GlobeNewswire

Arbutus Announces Presentations at HepDART 2017

27/11/2017 - 15:00

VANCOUVER, British Columbia and WARMINSTER, Pa., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today [...]

Analogic Celebrates 50 Years of Imaging Innovation at RSNA 2017

27/11/2017 - 15:00

PEABODY, Mass., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq: ALOG ), enabling the world’s medical imaging and aviation security technology, today achieves a significant milestone marking the 50 th [...]

Canada House Wellness Group Announces Extension of Closing Date for Convertible Debenture Unit Financing

27/11/2017 - 14:30

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 27, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) announces [...]

UroGen Pharma Announces Oral Presentation at Society of Urologic Oncology (SUO) Annual Meeting

27/11/2017 - 14:30

Principal Investigator Seth Lerner, M.D., to present design overview of ongoing Phase 3 OLYMPUS trial of MitoGel™ for the treatment of Low-Grade UTUC and data highlights from recently completed compassionate use program [...]

3D Signatures Inc. Announces Non-Brokered Private Placement to Raise $1,500,000 and Updates Previously Announced Brokered Private Placement

27/11/2017 - 14:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 27, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD ) (OTCQB:TDSGF) (FSE:3D0) (the " Company " or " 3DS ") [...]

T2 Biosystems to Attend the Global Mizuho Investor Conference

27/11/2017 - 14:00

LEXINGTON, Mass., Nov. 27, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced that John [...]

Eloxx Pharmaceuticals Announces First Patient Dosed in Phase 1b Clinical Trial

27/11/2017 - 14:00

Lead molecule targets genetic nonsense mutation in rare diseases Dose escalating study to enroll 36 subjects Data expected in the fourth quarter of 2018 SAN DIEGO and REHOVOT, Israel and BOSTON, Nov. 27, 2017 (GLOBE [...]

PositiveID Corporation to Present at the LD MICRO “Main Event” Investor Conference on December 6th

27/11/2017 - 14:00

DELRAY BEACH, Fla., Nov. 27, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that its Chairman and [...]

iCAD’s PowerLook® Tomo Detection Experiences Growing Adoption

27/11/2017 - 14:00

Company to Showcase Innovative Mammography Artificial Intelligence Solution at RSNA 2017 CHICAGO, Nov. 27, 2017 (GLOBE NEWSWIRE) -- RSNA 2017 -- iCAD, Inc. (NASDAQ: ICAD ), a global leader in medical technology [...]

Inovio Pharmaceuticals SynCon® TERT Cancer Immunotherapy Combined with Checkpoint Inhibitor Synergistically Shrinks Tumor and Improves Survival in Preclinical Tumor Model

27/11/2017 - 14:00

PLYMOUTH MEETING, Pa., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) demonstrated the synergistic effect of combining Inovio’s TERT (telomerase reverse transcriptase) cancer immunotherapy [...]

Golden Leaf Secures Cultivation License From Health Canada For State-of-the-Art Ontario Grow Facility

27/11/2017 - 14:00

PORTLAND, Ore., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]

Cancer Genetics Appoints Renowned Biotech Entrepreneur Dr. Thomas F. Widmann to its Board of Directors

27/11/2017 - 14:00

RUTHERFORD, N.J., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced the appointment [...]

Intra-Cellular Therapies to Participate at the 29th Annual Piper Jaffray Healthcare Conference

27/11/2017 - 14:00

NEW YORK, Nov. 27, 2017 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS") disorders, today [...]

Medovex Corporation Submits IDE with the Food and Drug Administration for its DenerveX System

27/11/2017 - 14:00

ATLANTA, Nov. 27, 2017 (GLOBE NEWSWIRE) -- Medovex Corporation (NASDAQ: MDVX ) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint [...]

aTyr Pharma Doses First Subjects in Phase 1 Trial of iMod.Fc (ATYR1923)

27/11/2017 - 14:00

– Second Physiocrine-based therapeutic candidate enters the clinic – – Top-line data expected in 2Q 2018 – – iMod.Fc (ATYR1923) to target interstitial lung diseases with an immune component – SAN DIEGO, Nov. 27, 2017 ( [...]

Novo Nordisk A/S - Share repurchase programme

27/11/2017 - 13:50

Bagsværd, Denmark, 27 November 2017 - On 1 November 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Avadel Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference

27/11/2017 - 13:30

DUBLIN, Ireland, Nov. 27, 2017 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL ), today announced that Mike Kanan, Chief Financial Officer, and Lauren Stival, Senior Director, Investor Relations, will [...]

TG Therapeutics Announces Initiation of National Cancer Institute/SWOG-Sponsored Randomized Phase II Trial in Follicular Lymphoma

27/11/2017 - 13:30

NEW YORK, Nov. 27, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics (NASDAQ: TGTX ) announced today that along with SWOG, the global cancer clinical trials group funded by the National Cancer Institute (NCI), it has initiated a [...]

Forward Pharma to Participate in Investor Conferences in December

27/11/2017 - 13:30

COPENHAGEN, Denmark, Nov. 27, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will participate in two [...]